Issue Brief
Operational and Policy Considerations in the Effectuation of Medicare’s Maximum Fair Drug Prices for Part D
October 16, 2025
Featured Experts: John M. Coster, PhD, RPh
Research
All Research Featured Research
News
Reform of Federal Drug Discount Program Should Target Misaligned Incentives
September 29, 2025
Featured Experts: Ryan Long, Karen Mulligan, PhD
News
Former FDA Leaders Say New Policies Needed to Boost Medical Innovation
September 26, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
News
Schaeffer Center White Paper Outlines FDA Reforms to Boost Pharmaceutical Innovation and Expand Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
White Paper
A Blueprint for FDA: Recommendations to Improve Innovation and Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
Journal Article
Measuring the Budget Impact of Nondiscriminatory Cost-Effectiveness
September 5, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Maria-Alice Manetas, Darius Lakdawalla, PhD
Perspective
Should the Government Control Drug Prices? Yes… Wise Regulation Will Reform an Out-of-Control Industry
September 2, 2025
Featured Experts: Paul Ginsburg, PhD, Steven M. Lieberman, MPhil, MA
Journal Article
Long-Term Value of Lecanemab to Individuals and Families
August 28, 2025
Featured Experts: Bryan Tysinger, PhD, Hanke Heun-Johnson, PhD, Julie Zissimopoulos, PhD
News
Narrower Coverage of MS Drugs Tied to Higher Relapse Risk
August 1, 2025
Featured Experts: Geoffrey Joyce, PhD
News
Delinking PBM Compensation From Drug List Prices Could Unleash Major Savings
July 24, 2025
Featured Experts: Geoffrey Joyce, PhD
Evidence Base
A Value-Based Price for Anti-Obesity Medications
July 17, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
Journal Article
Proposal for a Value-Based Agreement to Reimburse Anti-Obesity Medicines in Traditional Medicare
July 11, 2025
Featured Experts: Alison Sexton Ward, PhD, Erin Trish, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation
June 27, 2025
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
News
Most Medicare Beneficiaries May Pay More for Drugs Under the IRA
June 19, 2025
Featured Experts: Erin Trish, PhD
White Paper
Shifting Cost-Sharing Burden to Beneficiaries in Medicare Part D
June 19, 2025
Featured Experts: Erin Trish, PhD
News
Why Do Americans Pay More for Prescription Drugs?
June 12, 2025
Featured Experts: Darius Lakdawalla, PhD
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Testimony
Testimony on IRA Implementation’s Threat to Medicine
May 20, 2025
Featured Experts: Erin Trish, PhD
News
Pharmacies Excluded from Preferred Networks Face Much Higher Risk of Closure
May 5, 2025
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
Journal Article
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014–23
May 5, 2025
Featured Experts: Genevieve P. Kanter, PhD, Dima M. Qato, PharmD, MPH, PhD